ATE246924T1 - Neue therapeutische verwendung von nicergoline - Google Patents
Neue therapeutische verwendung von nicergolineInfo
- Publication number
- ATE246924T1 ATE246924T1 AT99956109T AT99956109T ATE246924T1 AT E246924 T1 ATE246924 T1 AT E246924T1 AT 99956109 T AT99956109 T AT 99956109T AT 99956109 T AT99956109 T AT 99956109T AT E246924 T1 ATE246924 T1 AT E246924T1
- Authority
- AT
- Austria
- Prior art keywords
- nicergoline
- therapeutic use
- new therapeutic
- preventing
- invention concerns
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9814793A FR2786100B1 (fr) | 1998-11-24 | 1998-11-24 | Nouvelle application therapeutique de la nicergoline |
| PCT/FR1999/002867 WO2000030643A1 (fr) | 1998-11-24 | 1999-11-22 | Nouvelle application therapeutique de la nicergoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE246924T1 true ATE246924T1 (de) | 2003-08-15 |
Family
ID=9533130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99956109T ATE246924T1 (de) | 1998-11-24 | 1999-11-22 | Neue therapeutische verwendung von nicergoline |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6469019B2 (de) |
| EP (1) | EP1133296B1 (de) |
| JP (1) | JP4637359B2 (de) |
| AT (1) | ATE246924T1 (de) |
| AU (1) | AU1278600A (de) |
| DE (1) | DE69910425T2 (de) |
| DK (1) | DK1133296T3 (de) |
| ES (1) | ES2200569T3 (de) |
| FR (1) | FR2786100B1 (de) |
| PT (1) | PT1133296E (de) |
| WO (1) | WO2000030643A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786101B1 (fr) * | 1998-11-24 | 2002-07-05 | Aventis Laboratoire | Utilisation de la nicergoline dans le traitement de la spasticite |
| US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
| US8669282B2 (en) * | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
| WO2006071919A2 (en) * | 2004-12-29 | 2006-07-06 | Hill's Pet Nutrition, Inc. | Methods for inhibiting a decline in learning and/or memory in animals |
| WO2006074089A2 (en) | 2004-12-30 | 2006-07-13 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| US8252742B2 (en) | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| BRPI0613000A2 (pt) * | 2005-07-14 | 2012-12-04 | Hills Pet Nutrition Inc | método para aumentar a longevidade de um animal, artigo de fabricação, kit, e, meio de comunicação de informação acerca de ou instruções para a administração a um animal velho de uma composição |
| DE102007052536A1 (de) * | 2007-11-01 | 2009-05-07 | Beiersdorf Ag | Wirkstoffkombinationen aus Anisfruchtextrakt und Weißen Teeextrakt |
| FR3000746A1 (fr) | 2013-01-04 | 2014-07-11 | Centre Nat Rech Scient | Peptide pour son utilisation dans le traitement des neuronopathies motrices |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3228943A (en) | 1962-06-11 | 1966-01-11 | Lumilysergol derivatives | |
| IT1227626B (it) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione |
| IT1252163B (it) * | 1991-12-03 | 1995-06-05 | Poli Ind Chimica Spa | Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica |
| JP2864885B2 (ja) * | 1992-07-02 | 1999-03-08 | 田辺製薬株式会社 | ニセルゴリン含有経口投与製剤 |
| IT1256743B (it) * | 1992-12-18 | 1995-12-15 | Giorgio Pifferi | Composizioni farmaceutiche a rilascio controllato contenenti nicergolina |
| FR2786101B1 (fr) * | 1998-11-24 | 2002-07-05 | Aventis Laboratoire | Utilisation de la nicergoline dans le traitement de la spasticite |
-
1998
- 1998-11-24 FR FR9814793A patent/FR2786100B1/fr not_active Expired - Fee Related
-
1999
- 1999-11-22 EP EP99956109A patent/EP1133296B1/de not_active Expired - Lifetime
- 1999-11-22 AT AT99956109T patent/ATE246924T1/de active
- 1999-11-22 DE DE69910425T patent/DE69910425T2/de not_active Expired - Lifetime
- 1999-11-22 JP JP2000583526A patent/JP4637359B2/ja not_active Expired - Fee Related
- 1999-11-22 DK DK99956109T patent/DK1133296T3/da active
- 1999-11-22 AU AU12786/00A patent/AU1278600A/en not_active Abandoned
- 1999-11-22 ES ES99956109T patent/ES2200569T3/es not_active Expired - Lifetime
- 1999-11-22 WO PCT/FR1999/002867 patent/WO2000030643A1/fr active IP Right Grant
- 1999-11-22 PT PT99956109T patent/PT1133296E/pt unknown
-
2001
- 2001-05-23 US US09/863,623 patent/US6469019B2/en not_active Expired - Lifetime
-
2002
- 2002-08-14 US US10/218,666 patent/US20030134869A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FR2786100A1 (fr) | 2000-05-26 |
| EP1133296A1 (de) | 2001-09-19 |
| ES2200569T3 (es) | 2004-03-01 |
| FR2786100B1 (fr) | 2002-03-01 |
| JP4637359B2 (ja) | 2011-02-23 |
| DE69910425T2 (de) | 2004-04-08 |
| DE69910425D1 (de) | 2003-09-18 |
| EP1133296B1 (de) | 2003-08-13 |
| PT1133296E (pt) | 2003-11-28 |
| DK1133296T3 (da) | 2003-11-17 |
| US20030134869A1 (en) | 2003-07-17 |
| WO2000030643A1 (fr) | 2000-06-02 |
| AU1278600A (en) | 2000-06-13 |
| US20010044448A1 (en) | 2001-11-22 |
| JP2002530336A (ja) | 2002-09-17 |
| US6469019B2 (en) | 2002-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69724016D1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege | |
| DE60037394D1 (de) | VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE | |
| ATE231724T1 (de) | Kombinationstherapie für die behandlung von psychosen | |
| DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
| ATE271038T1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
| DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
| ATE527022T1 (de) | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie | |
| ATE246924T1 (de) | Neue therapeutische verwendung von nicergoline | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE69822297D1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
| DE59704933D1 (de) | Verwendung von PHMB zur Behandlung von Tumorerkrankungen | |
| IL143279A0 (en) | Novel therapeutic application of low molecular weight heparin | |
| DE69806062T2 (de) | Kombinationstherapie zur behandlung von aids | |
| ATE238795T1 (de) | Verwendung von aminothiazolen zur wund- und hautbehandlung | |
| ATE247467T1 (de) | Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin | |
| DE59711240D1 (de) | Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge | |
| DE69936779D1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
| ATE291434T1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
| DE69813354T2 (de) | Mittel zur Behandlung von Herzkrankheiten | |
| NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
| DE69819503D1 (de) | Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose | |
| DE59712374D1 (de) | Verwendung von hcc-1 zur behandlung von thrombozytopenien | |
| DE69822628D1 (de) | Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo[2.1.5-cd]indolizin-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1133296 Country of ref document: EP |